亚洲图片国产日韩欧美_国产区精品欧美日韩在线蜜臀_韩国日本三级在线观看手机视频_影音先锋国产精品无码_亚洲日本va一区二区三区_亚洲精品无码丰满少妇av_天堂在线中文www_扒开粉嫩的小缝开始亲吻男女_尤蜜在线观看免费观看_久久毛片欧洲无码视频

×

本司產(chǎn)品僅用于科研,不用于臨床診斷和治療

全國免費熱線:400-999-2100

您身邊的細(xì)胞培養(yǎng)專家!

所有分類
  • 所有分類
  • 細(xì)胞系
  • 原代細(xì)胞
  • 血清
  • 細(xì)胞培養(yǎng)基
  • 輔助試劑
  • 細(xì)胞凋亡檢測試劑盒
  • 細(xì)胞房除菌產(chǎn)品
熱搜: 胎牛血清 VERO RAW264.7 成纖維細(xì)胞 間充質(zhì)干細(xì)胞 上皮細(xì)胞

忘記密碼

個人郵箱:
驗證碼: captcha

賬號激活

個人郵箱:
×
當(dāng)前位置:首頁 >> 產(chǎn)品中心 >> 細(xì)胞資源庫 >> 細(xì)胞系 >> 

產(chǎn)品中心Cell Resources

聯(lián)系我們CONTACT US

  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)

SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)

貨號:CL-0210

規(guī)格:1×10?cells/T25培養(yǎng)瓶

價格: ¥1600

生長培養(yǎng)基:MEM(含NEAA)10% FBS1% P/S

數(shù)量: - +

  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
  • SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)

推薦搭配

套餐1:

SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確) ¥1600
SiHa細(xì)胞專用培養(yǎng)基
  • ¥350
  • ¥450

現(xiàn)單獨購買該產(chǎn)品也可享受限時優(yōu)惠價!

細(xì)胞培養(yǎng)最優(yōu)解!

套餐組合價:¥1950¥2050

加入購物車

搭配套餐已成功加入購物車!

產(chǎn)品概述
產(chǎn)品信息
名稱 SiHa (人子宮頸鱗癌細(xì)胞) (STR鑒定正確)
別稱 Siha; SIHA
種屬
生長特性 貼壁細(xì)胞
細(xì)胞形態(tài) 上皮細(xì)胞樣
凍存條件 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮
培養(yǎng)方案A(默認(rèn))
生長培養(yǎng)基:
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
推薦傳代比例 1:3-1:4
推薦換液頻率 2-3次/周
參考資料(來源文獻)
背景描述 SiHa細(xì)胞是建自一個日本病人的外科手術(shù)的原位組織樣品。電鏡觀察表明,在SiHa細(xì)胞連接處有典型的橋粒,在SiHa細(xì)胞胞質(zhì)中有豐富的張力絲。在裸鼠中,SiHa細(xì)胞能形成低分化的表皮樣癌(Ⅲ級);SiHa細(xì)胞中,癌基因PRB和p53陽性。
年齡(性別) 女性;55歲
組織來源 子宮頸鱗癌
細(xì)胞類型 腫瘤細(xì)胞
腫瘤類型 宮頸癌細(xì)胞
生物安全等級 BSL-2 [Cells contain human papilloma virus]
倍增時間 ~50-60 hours
致瘤性 Yes, in nude mice; forms poorly differentiated epidermoid carcinoma (grade III).
基因表達情況 Oncogenes: p53+; pRB+
保藏機構(gòu) ATCC; HTB-35
STR鑒定
  • STR位點信息
    Amelogenin X
    CSF1PO 12
    D2S1338 24
    D3S1358 16,17
    D5S818 9
    D7S820 10
    D8S1179 13,16
    D13S317 11
    D16S539 12
    D18S51 15
    D19S433 14.2
    D21S11 31
    FGA 21
    PentaD 9
    PentaE 10,12
    TH01 6,9
    TPOX 8
    vWA 14,17
    D6S1043 18
    D12S391 19,22
    D2S441 10
  • STR鑒定圖
參考文獻
文獻列表
  • Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer(2022/09/04)

    作者:Xiaoqin Lu, Rui Li, Yanqi Ying

    期刊:Journal of Translational Medicine

    DOI:10.1186/s12967-022-03600-7

    影響因子 :7.400

    引用產(chǎn)品:CL-0101 CL-0210

  • Design of Selective PARP-1 Inhibitors and Antitumor Studies(2024/05/22)

    作者:Yiting Zhang, Xiangqian Li, Fang Liu

    期刊:JOURNAL OF MEDICINAL CHEMISTRY

    DOI:10.1021/acs.jmedchem.3c02460

    影響因子 :7.300

    引用產(chǎn)品:CL-0210

  • Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-κB(2021/01/19)

    作者:Wanyue Wang, Xin Li, Ye Xu

    期刊:Cellular Oncology

    DOI:10.1007/s13402-020-00582-w

    影響因子 :6.600

    引用產(chǎn)品:CL-0045 CL-0101 CL-0210

  • Prognosis, immune microenvironment, and personalized treatment prediction in Rho GTPase-activating protein 4-mutant cervical cancer: Computer strategies for precision oncology(2023/01/03)

    作者:Xiaoqin Lu, Yanqi Ying, Wenyi Zhang

    期刊:Life Sciences

    DOI:10.1016/j.lfs.2022.121360

    影響因子 :6.100

    引用產(chǎn)品:CL-0101 CL-0210

  • Long Intervening Noncoding 00467 RNA Contributes to Tumorigenesis by Acting as a Competing Endogenous RNA against miR-107 in Cervical Cancer Cells(2019/11/01)

    作者:Guangcai Li, Li Xin, Yongsheng Wang

    期刊:Am J Pathol

    DOI:10.1016/j.ajpath.2019.07.012

    影響因子 :6.000

    引用產(chǎn)品:CL-0101 CL-0210

  • Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial–mesenchymal transition by suppressing the TGF-β/smad pathway via binding to GREM1(2019/05/23)

    作者:Hui Miao, Nuan Wang, Linxin Shi

    期刊:Cancer Cell International

    DOI:10.1186/s12935-019-0852-8

    影響因子 :5.800

    引用產(chǎn)品:CL-0210

  • Synergistic effects of sodium butyrate and cisplatin against cervical carcinoma in vitro and in vivo(2022/10/21)

    作者:Huijun Chu, Xiaoyuan Sun, Jia Wang

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2022.999667

    影響因子 :5.738

    引用產(chǎn)品:CL-0210

  • Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor(2022/06/20)

    作者:Na Qu, Ruizhe Wang, Yiming Meng

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2022.108933

    影響因子 :5.714

    引用產(chǎn)品:CL-0101 CL-0210

  • 3-Hydroxymorindone from Knoxia roxburghii (Spreng.) M. A. Rau induces ROS-mediated mitochondrial dysfunction cervical cancer cells apoptosis via inhibition of PI3K/AKT/NF-κB signaling pathway(2023/03/11)

    作者:Xiaojiao Chen, Zhibo Liu, Xue Li

    期刊:Journal of Functional Foods

    DOI:10.1016/j.jff.2023.105498

    影響因子 :5.600

    引用產(chǎn)品:164210 164210-50 CL-0045 CL-0210

  • Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway(2023/01/03)

    作者:Wei Hu, Yaorui Hu, Yao Pei

    期刊:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

    DOI:10.3390/ijms24010861

    影響因子 :5.600

    引用產(chǎn)品:CL-0101 CL-0210

  • Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b+ NCR1+ NKs of tumor microenvironment(2023/09/21)

    作者:Na Qu, Yiming Meng, Jingbo Zhai

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2023.110967

    影響因子 :5.600

    引用產(chǎn)品:CL-0101 CL-0210

  • The anticancer effect of extract of medicinal mushroom Sanghuangprous vaninii against human cervical cancer cell via endoplasmic reticulum stress-mitochondrial apoptotic pathway(2021/6/17)

    作者:Pingya He, Yuhao Hou, Yue Yang

    期刊:Journal Of Ethnopharmacology

    DOI:10.1016/j.jep.2021.114345

    影響因子 :5.400

    引用產(chǎn)品:CL-0210 CL-0215

  • USF1 regulated circPRDM4 modulates tumorigenesis and immune escape in chemoresistant cervical cancer(2023/09/04)

    作者:Yan Zhang, Xing Li, Jun Zhang

    期刊:JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

    DOI:10.1111/jcmm.17945

    影響因子 :5.300

    引用產(chǎn)品:CL-0101 CL-0210

  • KMT2A regulates cervical cancer cell growth through targeting VDAC1.(2020/05/21)

    作者:Changlin Zhang, Yijun Hua, Huijuan Qiu

    期刊:Aging-US

    DOI:10.18632/aging.103229

    影響因子 :5.200

    引用產(chǎn)品:CL-0048 CL-0210

  • CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells(2022/02/15)

    作者:Xiaoxi Zhang, Yunxia Sun, Siyao Cheng

    期刊:Cell Cycle

    DOI:10.1080/15384101.2022.2039981

    影響因子 :5.173

    引用產(chǎn)品:CL-0048 CL-0210

  • Integral membrane protein 2A enhances sensitivity to chemotherapy via notch signaling pathway in cervical cancer(2021/12/07)

    作者:Yan Li, Jianhua Wang, Chengzhen Gao

    期刊:Bioengineered

    DOI:10.1080/21655979.2021.2001218

    影響因子 :4.900

    引用產(chǎn)品:CL-0101 CL-0210 PM150210

  • Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9(2022/04/07)

    作者:Caimei Wang, Yiyuan Wang, Congrong Liu

    期刊:Bioengineered

    DOI:10.1080/21655979.2022.2061144

    影響因子 :4.900

    引用產(chǎn)品:CL-0045 CL-0210

  • Lymph node metastasis-related gene signature shows good performance in predicting prognosis and immune infiltration in cervical cancer(2023/06/22)

    作者:Yilin Guo, Lu Wang, Zhen Xu

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2023.1190251

    影響因子 :4.700

    引用產(chǎn)品:CL-0210

  • The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer(2024/01/15)

    作者:Haizhou Ji, Bin Liu, Mi Ren

    期刊:Expert Review of Clinical Immunology

    DOI:10.1080/1744666X.2024.2305808

    影響因子 :4.400

    引用產(chǎn)品:CL-0210

  • Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p(2020/8/1)

    作者:Lin Lin, Bing Xin, Tao Jiang

    期刊:MOLECULAR AND CELLULAR BIOCHEMISTRY

    DOI:10.1007/s11010-020-03853-0.?

    影響因子 :4.300

    引用產(chǎn)品:CL-0210

  • USP21 regulates Hippo signaling to promote radioresistance by deubiquitinating FOXM1 in cervical cancer(2021/11/25)

    作者:Zhengliang Li , Xiaojing Liu , Haizhou Yu

    期刊:Human Cell

    DOI:10.1007/s13577-021-00650-9

    影響因子 :4.300

    引用產(chǎn)品:CL-0045 CL-0101 CL-0155 CL-0210

  • OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway(2022/09/29)

    作者:Limin Zhou, Hongying Li, Dunlan Zhang

    期刊:ONCOLOGY REPORTS

    DOI:10.3892/or.2022.8419

    影響因子 :4.200

    引用產(chǎn)品:CL-0045 CL-0048 CL-0155 CL-0210

  • Nocardia rubra cell-wall skeleton influences the development of cervical carcinoma by promoting the antitumor effect of macrophages and dendritic cells(2022/01/07)

    作者:Siyang Zhang, Han Wang, Yisi Liu

    期刊:Cancer Medicine

    DOI:10.1002/cam4.4526

    影響因子 :4.000

    引用產(chǎn)品:164210 164210-50 CL-0101 CL-0210

  • HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression(2024/01/11)

    作者:Jianing Zhang, Xiaohui Yu, Yi Guo

    期刊:Cancer Medicine

    DOI:10.1002/cam4.6875

    影響因子 :4.000

    引用產(chǎn)品:CL-0210

  • APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway(2024/03/30)

    作者:Qi Wang, Bingyu Wang, Wenjing Zhang

    期刊:ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

    DOI:10.1016/j.abb.2024.109983

    影響因子 :3.900

    引用產(chǎn)品:CL-0210

  • Transient receptor potential channels’ genes forecast cervical cancer outcomes and illuminate its impact on tumor cells(2024/05/09)

    作者:Shan Jiang, Xuefen Lin, Qiaoling Wu

    期刊:Frontiers in Genetics

    DOI:10.3389/fgene.2024.1391842

    影響因子 :3.700

    引用產(chǎn)品:CL-0210

  • Characterization of the microenvironment in different immune-metabolism subtypes of cervical cancer with prognostic significance(2023/02/03)

    作者:Wujiang Lai, Jinrong Liao, Xiaoxuan Li

    期刊:Frontiers in Genetics

    DOI:10.3389/fgene.2023.1067666

    影響因子 :3.700

    引用產(chǎn)品:CL-0045 CL-0048 CL-0101 CL-0210

  • Circ_0005615 promotes cervical cancer cell growth and metastasis by modulating the miR-138-5p/KDM2A axis(2023/07/02)

    作者:Xiaoning Luo, Jiewen Liu, Xiangcai Wang

    期刊:JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

    DOI:10.1002/jbt.23410

    影響因子 :3.600

    引用產(chǎn)品:CL-0005 CL-0048 CL-0210 PM150110 PM150411

  • Hypoxic tumor cell-derived small extracellular vesicle miR-152-3p promotes cervical cancer radioresistance through KLF15 protein(2023/11/07)

    作者:Junying Zhou, Ningjing Lei, Wanjia Tian

    期刊:Radiation Oncology

    DOI:10.1186/s13014-023-02369-3

    影響因子 :3.600

    引用產(chǎn)品:CL-0210

  • Inhibition of miR-574-5p suppresses cell growth and metastasis and enhances chemosensitivity by targeting RNA binding protein QKI in cervical cancer cells(2019/11/30)

    作者:Rui Tong, Jingru Zhang, Chunyan Wang

    期刊:Naunyn-Schmiedebergs Archives of Pharmacology

    DOI:10.1007/s00210-019-01772-6

    影響因子 :3.600

    引用產(chǎn)品:CL-0045 CL-0048 CL-0101 CL-0210

  • USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination(2024/04/16)

    作者:Na Wang, Jing Xu, Yujing Wang

    期刊:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

    DOI:10.1007/s00432-024-05710-9

    影響因子 :3.600

    引用產(chǎn)品:CL-0210

  • hsa_circ_0119412 overexpression promotes cervical cancer progression by targeting miR-217 to upregulate anterior gradient 2(2022/03/11)

    作者:Yumei Lv,?Mingyi Wang,?Mingli Chen

    期刊:Journal Of Clinical Laboratory Analysis

    DOI:10.1002/jcla.24236

    影響因子 :3.124

    引用產(chǎn)品:CL-0045 CL-0048 CL-0101 CL-0210

  • LINC00460 knockdown sensitizes cervical cancer to cisplatin by downregulating TGFBI(2023/12/28)

    作者:Ping Tian, Yuanyuan Feng, Ling Tao

    期刊:Chemical Biology & Drug Design

    DOI:10.1111/cbdd.14424

    影響因子 :3.000

    引用產(chǎn)品:CL-0210

  • Transcription factor Dp-1 knockdown downregulates thymidine kinase 1 expression to protect against proliferation and epithelial-mesenchymal transition in cervical cancer(2023/09/16)

    作者:Mei Wu, Mingji Ye

    期刊:FUNCTIONAL & INTEGRATIVE GENOMICS

    DOI:10.1007/s10142-023-01218-6

    影響因子 :2.900

    引用產(chǎn)品:CL-0045 CL-0048 CL-0210 CL-0350 CP-H059

  • Artesunate promotes cervical cancer cell apoptosis by regulating Bcl2 family molecules and reducing the mitochondrial membrane potential(2024/05/14)

    作者:Qianying Zhang, Xing Li, Caiyi He

    期刊:Oncology Letters

    DOI:10.3892/ol.2024.14447

    影響因子 :2.900

    引用產(chǎn)品:CL-0210

  • SHCBP1 contributes to the proliferation and self?renewal of cervical cancer cells and activation of the NF?κB signaling pathway through EIF5A(2023/04/21)

    作者:Boya Deng, Ailin Li, Ying Zhu

    期刊:Oncology Letters

    DOI:10.3892/ol.2023.13832

    影響因子 :2.900

    引用產(chǎn)品:CL-0045 CL-0048 CL-0210 PM150312

  • N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma(2024/04/28)

    作者:Qingqing Tian, Juqing Huang, Qin Zhang

    期刊:CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

    DOI:10.1111/1440-1681.13864

    影響因子 :2.900

    引用產(chǎn)品:CL-0210

  • FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma(2022/08/28)

    作者:Yanru Yang, Yun Zhao, Guorui Sun

    期刊:PATHOLOGY RESEARCH AND PRACTICE

    DOI:10.1016/j.prp.2022.154090

    影響因子 :2.800

    引用產(chǎn)品:CL-0045 CL-0048 CL-0210

  • TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma(2023/07/23)

    作者:Yanru Yang, Saijie Zuo, Wenqing Li

    期刊:PATHOLOGY RESEARCH AND PRACTICE

    DOI:10.1016/j.prp.2023.154710

    影響因子 :2.800

    引用產(chǎn)品:CL-0045 CL-0048 CL-0210

  • CLCA2 overexpression suppresses epithelial-to-mesenchymal transition in cervical cancer cells through inactivation of ERK/JNK/p38-MAPK signaling pathways(2022/10/25)

    作者:Wenhu Xin, Jian Zhang, Haibin Zhang

    期刊:BMC Molecular and Cell Biology

    DOI:10.1186/s12860-022-00440-7

    影響因子 :2.800

    引用產(chǎn)品:CL-0045 CL-0101 CL-0210

  • ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma(2022/12/05)

    作者:Qingge Jia, Junyang Song, Tianqi Xu

    期刊:PATHOLOGY RESEARCH AND PRACTICE

    DOI:10.1016/j.prp.2022.154268

    影響因子 :2.800

    引用產(chǎn)品:CL-0045 CL-0048 CL-0210

  • Mesencephalic astrocyte-derived neurotrophic factor inhibits cervical cancer progression via regulating macrophage phenotype(2024/05/12)

    作者:Miaomiao Huang, Jingjing Hu, Yueran Chen

    期刊:MOLECULAR BIOLOGY REPORTS

    DOI:10.1007/s11033-024-09602-6

    影響因子 :2.800

    引用產(chǎn)品:CL-0210

  • Relevance research between the expression of p16INK4a, Notch1, and hTERC genes: The development of HPV16‐positive cervical cancer(2020/1/24)

    作者:Wenyan Huo, Shuaiyu Zhai, Yanbo Wang

    期刊:Journal Of Clinical Laboratory Analysis

    DOI:10.1002/jcla.23207

    影響因子 :2.700

    引用產(chǎn)品:CL-0210

  • Regulation of Cervical Cancer Development by a Novel Circ_0000212/miR-1236-3p/GREM1 ceRNA Crosstalk(2023/03/23)

    作者:Yajun Zhang, Peili Liu, Daoqing Wen

    期刊:MOLECULAR BIOTECHNOLOGY

    DOI:10.1007/s12033-023-00721-2

    影響因子 :2.600

    引用產(chǎn)品:CL-0045 CL-0210 CM-0045 CM-0122 CM-0210

  • Circular RNA circ_0000119 promotes cervical cancer cell growth and migration via miR-433-3p/PAK2 axis(2023/08/04)

    作者:Junxiao Zhang, Guanghua Chu, Lihua Zheng

    期刊:JOURNAL OF APPLIED GENETICS

    DOI:10.1007/s13353-023-00772-w

    影響因子 :2.400

    引用產(chǎn)品:CL-0048 CL-0210

  • Cellular Retinoic Acid Binding Protein 2 (CRABP2), Up-regulated by HPV E6/E7, Leads to Aberrant Activation of the Integrin β1/FAK/ERK Signaling Pathway and Aggravates the Malignant Phenotypes of Cervical Cancer(2023/11/24)

    作者:Jiaxin Liu, Lu Tang, Wenzhu Chu

    期刊:BIOCHEMICAL GENETICS

    DOI:10.1007/s10528-023-10568-6

    影響因子 :2.400

    引用產(chǎn)品:CL-0210

  • Circular RNA circVPRBP serves as a microRNA-106b-5p sponge to regulate proliferation and metastasis of cervical cancer cells via tripartite motif-containing protein 3(2022/08/10)

    作者:Yingying Jiang, Wei Xu, Junzhen Tao

    期刊:ANTI-CANCER DRUGS

    DOI:10.1097/CAD.0000000000001335

    影響因子 :2.300

    引用產(chǎn)品:CL-0048 CL-0210 CM-0210

  • PLAC8 contributes to the malignant behaviors of cervical cancer cells by activating the SOX4-mediated AKT pathway(2023/01/05)

    作者:Boya Deng, Siyang Zhang, Yingying Zhou

    期刊:HISTOCHEMISTRY AND CELL BIOLOGY

    DOI:10.1007/s00418-022-02175-0

    影響因子 :2.300

    引用產(chǎn)品:CL-0045 CL-0048 CL-0210

  • HIV gp120/Tat protein-induced epithelial–mesenchymal transition promotes the progression of cervical lesions(2023/11/19)

    作者:Peizhi Wang, Baojun Yang, Huang Huang

    期刊:AIDS Research and Therapy

    DOI:10.1186/s12981-023-00577-1

    影響因子 :2.200

    引用產(chǎn)品:CL-0210

  • LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and c(2022/03/01)

    作者:Limei Zhang, Yufei Cai, Chenchen Tian

    期刊:Journal Of Obstetrics And Gynaecology Research

    DOI:10.1111/jog.15209

    影響因子 :1.600

    引用產(chǎn)品:CL-0048 CL-0101 CL-0155 CL-0210

  • 點擊展開收起列表
FAQs

Q:{{item.question}}

A:

暫無數(shù)據(jù)
產(chǎn)品資料
注:百度瀏覽器無法支持掃一掃功能,請輸入識別碼,獲取相應(yīng)產(chǎn)品資料

識別碼示意圖

確定
邱國娜/胡文君

邱國娜/胡文君

【 上海 】

何帆

何帆

【 陜西、甘肅、寧夏、青海、新疆 】

 熊經(jīng)理

熊經(jīng)理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

劉本佳

劉本佳

【江蘇(除南京外)】

章臣雄

章臣雄

【 廣州 】

杜焱煒

杜焱煒

【 四川、云南、西藏 】

田博浩

田博浩

【 重慶、貴州 】

石文平

石文平

【 北京、遼寧 】

胡文君

胡文君

【江西】

李榮楓

李榮楓

【 天津、河北、內(nèi)蒙古、山西 】

陳雨蘭

陳雨蘭

【 山東 】

尹國文

尹國文

【浙江】

唐小花

唐小花

【 吉林、黑龍江 】

付帥

付帥

【 安徽 】

朱俊宇

朱俊宇

【 河南、廣西 】

李慶祖

李慶祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文強

梅文強

【福建】

林釗光

林釗光

【南京】

微信掃一掃咨詢

微信掃一掃咨詢

在線客服
關(guān)閉
在線咨詢
聯(lián)系銷售

關(guān)注微信公眾號